DBS: a UK (MHRA) regulatory perspective

被引：11

|

作者：

Beharry, Michelle ^{[1
]}

机构：

[1] UK MHRA, London SW8 5NQ, England

来源：

BIOANALYSIS | 2010年 / 2卷 / 08期

关键词：

D O I：

10.4155/BIO.10.109

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

收藏

页码：1363 / 1364

页数：2

相关论文

共 50 条

[1] UK NIBSC to merge with MHRA
Reactions Weekly, 2012, 1428 (1) : 3 - 3
[2] A regulatory perspective of decommissioning in the UK
Mason, DJ
INTERNATIONAL CONFERENCE ON NUCLEAR DECOMMISSIONING '98, 1998, 1998 (12): : 239 - 248
[3] Urine analysis - an MHRA perspective
Halloran, S. P.
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2004, 56 : S99 - S99
[4] Quality considerations of paediatric investigation plans for monoclonal antibodies: A regulatory perspective from the MHRA
Hussain, Nasir
Siapkara, Angeliki
Branch, Sarah
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 492 (1-2) : 338 - 340
[5] UK is a counterfeit hub says MHRA
不详
EJHP PRACTICE, 2008, 14 (02): : 15 - 15
[6] UK MHRA to implement name changes
Reactions Weekly, 2003, 956 (1) : 2 - 2
[7] SCRAMBLING FOR UK DBS
IVALL, T
ELECTRONICS & WIRELESS WORLD, 1988, 94 (1634): : 1207 - 1207
[8] UK MHRA and researchers to collaborate on drug safety
Reactions Weekly, 2006, 1096 (1) : 3 - 3
[9] UK MHRA update dosing instructions for saquinavir
Reactions Weekly, 2010, 1332 (1) : 2 - 2
[10] Safety data to be published on UK MHRA website
Reactions Weekly, 2005, 1035 (1) : 2 - 2

← 1 2 3 4 5 →